Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Alexion's C5 complement inhibitor effective in murine lupus model

Aug. 23, 1996

Cyclooxygenase-2 inhibitors from Merck Frosst

Aug. 23, 1996

Hyanalgese-D demonstrates negative efficacy in U.S. phase III trial

Aug. 23, 1996

KF-20444: Kyowa Hakko's novel antirheumatic agent

Aug. 23, 1996

Antiarthritic MMP inhibitor described by Chugai

Aug. 16, 1996

Kureha discloses MMP-inhibitory esculetin derivatives

Aug. 16, 1996

Nisshin Flour Milling describes agents for septic shock

Aug. 16, 1996

P-selectin inhibitors reported by BMS

Aug. 16, 1996

MGI Pharma issued Israeli marketing approval for Salagen line extension

Aug. 9, 1996

Palauolol: A novel antiinflammatory phospholipase A2 inhibitor

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...